Citigroup upgraded Core Labs from Sell to Neutral and set a new price target of $16.00 from $15.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/12/2025 | $15.00 → $16.00 | Sell → Neutral | Citigroup |
| 6/30/2023 | $22.00 → $21.00 | Neutral → Sell | Citigroup |
| 4/18/2023 | $21.50 | Neutral → Underperform | BofA Securities |
| 1/9/2023 | Underperform → Neutral | BofA Securities | |
| 10/7/2022 | $24.00 → $17.00 | Sell → Neutral | Citigroup |
| 9/26/2022 | $20.00 | Equal-Weight → Underweight | Morgan Stanley |
| 4/18/2022 | $19.50 → $21.30 | Neutral → Underweight | Piper Sandler |
| 1/18/2022 | $32.00 → $30.00 | Equal-Weight | Morgan Stanley |
HOUSTON, Sept. 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its third quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on October 23, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on October 22, 2025, and may be accessed through the Company's website at www.corelab.com. To log on to the listen-only webcast, visit www.corelab.com/investors at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a
REVENUE OF $130.2 MILLION, UP 5% SEQUENTIALLY AND FLAT YEAR-OVER-YEAROPERATING INCOME OF $15.3 MILLION; EX-ITEMS, $14.5 MILLION, UP OVER 23% SEQUENTIALLY AND DOWN 11% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 11%, EXPANDED 160 BASIS POINTS SEQUENTIALLY, WITH INCREMENTAL MARGINS, EX-ITEMS, OF 41%GAAP EPS OF $0.22; EX-ITEMS, $0.19, UP 33% SEQUENTIALLY, AND DOWN 14% YEAR-OVER-YEARCOMPANY REPURCHASED 237,632 SHARES OF COMMON STOCK, A VALUE OF $2.7 MILLION FREE CASH FLOW OF $10.4 MILLION, UP OVER 160% SEQUENTIALLYNET DEBT REDUCED BY $9.1 MILLION; DEBT LEVERAGE RATIO IMPROVED TO 1.27 COMPANY ANNOUNCES Q2 2025 QUARTERLY DIVIDEND HOUSTON, July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYS
HOUSTON, June 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its second quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on July 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on July 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay a
4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
3 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
SCHEDULE 13G/A - Core Laboratories Inc. /DE/ (0001958086) (Subject)
SCHEDULE 13G/A - Core Laboratories Inc. /DE/ (0001958086) (Subject)
10-Q - Core Laboratories Inc. /DE/ (0001958086) (Filer)
Citigroup upgraded Core Labs from Sell to Neutral and set a new price target of $16.00 from $15.00 previously
Citigroup downgraded Core Labs from Neutral to Sell and set a new price target of $21.00 from $22.00 previously
BofA Securities downgraded Core Labs from Neutral to Underperform and set a new price target of $21.50
HOUSTON, Sept. 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its third quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on October 23, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on October 22, 2025, and may be accessed through the Company's website at www.corelab.com. To log on to the listen-only webcast, visit www.corelab.com/investors at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a
REVENUE OF $130.2 MILLION, UP 5% SEQUENTIALLY AND FLAT YEAR-OVER-YEAROPERATING INCOME OF $15.3 MILLION; EX-ITEMS, $14.5 MILLION, UP OVER 23% SEQUENTIALLY AND DOWN 11% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 11%, EXPANDED 160 BASIS POINTS SEQUENTIALLY, WITH INCREMENTAL MARGINS, EX-ITEMS, OF 41%GAAP EPS OF $0.22; EX-ITEMS, $0.19, UP 33% SEQUENTIALLY, AND DOWN 14% YEAR-OVER-YEARCOMPANY REPURCHASED 237,632 SHARES OF COMMON STOCK, A VALUE OF $2.7 MILLION FREE CASH FLOW OF $10.4 MILLION, UP OVER 160% SEQUENTIALLYNET DEBT REDUCED BY $9.1 MILLION; DEBT LEVERAGE RATIO IMPROVED TO 1.27 COMPANY ANNOUNCES Q2 2025 QUARTERLY DIVIDEND HOUSTON, July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYS
HOUSTON, June 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its second quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on July 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on July 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay a
SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)
SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)
SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)